The family provided informed consent for research and publication in act to Helsinki Declaration. Whole-exome sequencing was performed on genomic DNA of the proband using Ion AmpliSeq™ RDY Exome Kit with the Ion Proton System (Life Technologies). After the run, the sequences were aligned to the hg19/GRCh37 reference genome and the variants annotated by ANNOVAR. SNPs and Indels were filtered to identify the disease-causing variant and the related gene. Exonic and splice-site variants were selected for minor allele frequency (MAF) inferior to 1%, according to the information in the European population of the 1,000 Genome Project, NHLBI Exome Sequencing Project and an in-house database. Functional impact of the remaining variants was evaluated based on the scores provided by SIFT, PolyPhen-2, MutationTaster, and CADD software. Inter-species conservation scores were provided by PhyloP and GERP++ software.
The genes related with ARS phenotype, FOXC1, PIXT2, CYP1B1, and PRDM5, were considered as possible candidate genes and According to this data, we hypothesize that the de novo mutation identified in our study can create a hypermorphic allele, being responsible for the ARS phenotype observed in the patient.
The mechanism behind the development of glaucoma caused by FOXC1 disruption is not clearly understood. This transcription factor is expressed during eye organogenesis in the periocular mesenchyme, trabecular meshwork, sclera, and conjunctival epithelium (Kidson, Kume, Deng, Winfrey, & Hogan, 1999) . It has a significant role in the normal corneal development, preserving corneal transparency by regulating vascular growth, and is also involved in the correct iris and trabecular meshwork formation (Kidson et al., 1999; Seo et al., 2012) .
Studies performed in human trabecular meshwork (TM) cells revealed the important role of FOXC1 in the response to oxidative stress and FOXC1 dysregulation results in TM cell death. The loss of TM cellularity will prevent aqueous humor uptake with a consequent increase in intraocular pressure (IOP), a major risk factor for the development of glaucoma (Berry et al., 2008; Ito, Goping, Berry, & Walter, 2014) .
In addition to the candidate approach, all exonic and splice site variants, excluding synonymous variants, were evaluated for pathogenicity according to ClinVar database classification or for association with a disease on the GWAS catalog. The purpose of this analysis was to find possible associations between the other variants and the patient's features. A common previously described variant in COL11A1
identified by GWAS as a susceptibility locus for primary angle closure glaucoma (PACG) (Vithana et al., 2012) was also found at heterozygote state in the patient: p.Pro1323Leu (c.3968C > T, rs3753841).
COL11A1 encodes the alpha chain of collagen type XI and pathogenic mutations in this gene are causative of syndromes with ocular involvement. This protein is a component of the extracellular matrix of human TM and, therefore, contributes to its structure (Acott & Kelley, 2008; Vithana et al., 2012) . Despite rs3753841 being predicted to have a moderate effect on the protein, a small aberrant activity or expression, in the presence of the hypermorphic FOXC1 allele, could contribute to a disruption of the TM and aqueous humor drainage with IOP increase. Further studies will clarify the possible impact of this variant in association with FOXC1 in the pathogenesis of glaucoma in ARS patients.
In conclusion, molecular screening by WES for ARS which has genetic heterogeneity has led to the identification of a novel nonsense mutation in FOXC1. This variant expanded the spectrum of FOXC1 mutations associated with ARS. WES leads to fast, easy screening of several genes simultaneously to identify genetic etiopathogenesis and in cases where surveillance and treatment strategies are based on molecular data could be considered as the first tier testing.
Furthermore, WES analysis may provide additional data on accompanying variants which may also have an impact on the clinical phenotype.
